TURNSTONE BIOLOGICS CORP (TSBX) Stock Analyst Ratings
NASDAQ:TSBX - Nasdaq - US90042W1009 - Common Stock
ChartMill assigns a Buy % Consensus number of 48% to TSBX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.47. This target is 453.94% above the current price.
TSBX was analyzed by 8 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about TSBX.
In the previous month the buy percentage consensus was at a similar level.
TSBX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-14 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-08-19 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-19 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-08-15 | B of A Securities | Initiate | Buy |
| 2023-08-15 | Piper Sandler | Initiate | Overweight |